Significance of intraglomerular expression of α-smooth muscle actin, desmin, and PDGF receptor on glomerulosclerosis in the rat remnant kidney model

Journal of Toxicologic Pathology

Volumn 11, Issue 4, 1998, Pages 229-234

  Shimo, Takeo ^a   Ohshita, Masafumi ^a   Katayama, Junichi ^a   Saito, Akemi ^a   Aoki, Yasuji ^a   Okezaki, Eiichi ^a   Nagata, Osamu ^a  

^a Abbott Japan Co Ltd   (Japan)

Author keywords

3 4 Nephrectomy; Desmin; Glomerulosclerosis; Mesangial cells; Pathomechanism; PDGF receptor; Rat; SMA

Indexed keywords

EID: 54749140082     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.11.229     Document Type: Article

References (31)

1. Klahr S, Schreiner G, and Ichikawa I. The progression of renal disease. N Engl J. Med 1988 ; 318 : 1657-1666.
2. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzi P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, and Johnson RJ. Glomerular cell proliferation and PDGF expression preceede glomerulosclerosis in the remnant kidney model. Kidney Int 1992 ; 41 : 297-309.
3. Zoja C, Perico N, Bergamelli A, Pasini M, Morigi M, Dadan J, Belloni A, Bertani T, and Remuzzi G. Ticlopidine prevents renal disease progression in rats with reduced renal mass. Kidney Int 1990 ; 37 : 934-942.
4. Ichikawa I, Yoshida Y, Fogo A, Purkerson ML, and Klahr S. Effect of hepalin on the glomerular structure and function of remnant nephrons. Kidney Int 1988 ; 34 : 638-644.
5. Chanutin A, and Ferris EB. Experimental renal insufficiency produced by partial nephrectomy. I Control Diet Arch Int Med 1932 ; 49 : 767-772.
6. Purkerson ML, Hoffsten PE, and Klahr S : Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 1976 ; 9 : 407-417.
7. Olivetti G, Anversa P, Rigamonti W, Vitali-Mazza L, and Loud AV. Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. J Cell Biol 1977 ; 75 : 573-580.
8. Shea SM, Raskova J, and Morrison AB. A stereologic study of glomerular hypertrophy in the subtottaly nephrectomized rat. Am J Pathol 1978 ; 90 : 201-210.
9. Olson JL, Hostetter TH, Rennke HG, Brenner BM, and Venka-Tachalam MA. Mechanisms of altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982 ; 22 : 112-116.
10. Meyer TW, and Brenner BM. The contribution of glomerular hemodynamic alterations to progressive renal disease. In : The Progressive Nature of Renal Disease, Mitch WE, Brenner BM, and Stein JH (eds), New York, Churchill Livingstone, 116, 1986.
11. Fogo A, and Ichikawa I. Evidence for the central role of glomerular growth promoters in the development of sclerosis. Sem Nephrol 1989 ; 9 : 329-342.
12. Rennke HG. Structural alterations associated with glomerular hyperfiltration. In : The Progressive Nature of Renal Disease, Mitch WE, Brenner BM, and Stein JH (eds), New York, Churchill Livingstone, 111-113, 1986.
13. Rennke HG, and Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989 ; 13 : 443-456.
14. Diamond JR, and Karnovsky MJ. Focal and segmental glomerular sclerosis : Analogies to atherosclerosis. Kidney Int 1988 ; 33 : 917-924.
15. Grond J, Koudstaal J, and Elema DJ. Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis. Kidney Int 1985 ; 27 : 405-410.
16. Keane WF, and Raji L. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Lab Invest 1985 ; 52 : 599-604.
17. Schreiner GF. Pathways leading from glomerular injury to glomerulosclerosis. Contrib Nephrol 1990 ; 86 : 1-18.
18. Schmilz PG, Kasiske BL, O'Donnell MP, and Keane WF. Lipids and progressive renal injury. Sem Nephrol 1989 ; 9 : 354-369.
19. Shultz PJ, DiCorleto PE, Silver BJ, and Abboud HE. Mesangial cells, express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988 ; 255 : F674-F684.
20. McNamara MM, and Ballermann BJ. Influence of tarnsforming growth factor-β (TGF-β) and glomerular endothelial cell (EN) conditioned medium (CM) on mesangial cell (MC) matrix synthesis, (abstract) Kidney Int 1989; 35: 432.
21. Border W, Okuda S, Languino L, and Ruoslahi E. Transforming growth factor (TGF β) uniquely regulates production and structure of glomerular extracellular matrix proteoglycanes. (abstract) Kidney Int 1989 ; 35 : 341.
22. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, McDonell RC, and Ichikawa I. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990; 38: 115-123.
23. Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, and Klahr S. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 1985 ; 82 : 193-197.
24. Ross R. Platelet-derived growth factor. Lancet I 1989 : 1179-1182.
25. Silver BJ, Jaffer FE, and Abbout HE. Platelet-derived growth factor synthesis in mesangial cells. Induction by multiple peptide mitogen. Proc Natl Acad Sci USA 1988 ; 86 : 1056-1060.
26. Mene P, Simonson MS, and Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989 ; 69 : 1347-1424.
27. Floege J, Topley N, and Resch K. Regulation of mesangial cell proliferation. Am J Kidney Dis 1991 ; 17 : 673-676.
28. Diamond JR, Goor HV, Ding G, and Engelmyer E. Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995 ; 146 : 121-129.
29. Gabbiani G. The biology of the myofibroblast. Kidney Int 1992 ; 41: : 530-532.
30. Yaoita E, Kazama T, Kawasaki K, Miyazaki S, Yamamoto T, and Kihara I. In vitro characteristics of rat mesangial cells in comparison with aortic smooth muscle cells and dermal fibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol 1985 ; 49 : 285-294.
31. Massague J. The transforming growth factor-β family. Anal Biochem 1990 ; 6 : 597-641.